• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Guardian Pharmacy Services Inc.

    3/26/26 7:20:13 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $GRDN alert in real time by email
    DEFA14A 1 d54280ddefa14a.htm DEFA14A DEFA14A
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934

     

     

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material Pursuant to § 240.14a-12

    Guardian Pharmacy Services, Inc.

    (Name of Registrant as Specified in Its Charter)

    N/A

    (Name of Person(s) Filing Proxy Statement if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     


    LOGO

     

      P.O. BOX 8016, CARY, NC 27512-9903

     

     

    LOGO

     

      LOGO

     

     

    Guardian Pharmacy Services, Inc.

     

    Annual Meeting of Stockholders

     

    Tuesday, May 5, 2026 1:00 PM, Eastern Time

     

    8909 Purdue Road, Suite 500, Indianapolis, IN 46268

     

     

    For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/GRDN

     

    To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

     

    This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

     

    Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the Internet.

     

    If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before April 24, 2026.

      

    LOGO

     

     

     

    Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report on Form 10-K

     

    Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On May 5, 2026 For Stockholders of record as of March 13, 2026

     

    To order paper materials, use one of the following methods.

     

    LOGO

     

    Internet:

    www.investorelections.com/GRDN

     

      LOGO

    Call:

    1-866-648-8133

     

      LOGO

    Email:

    [email protected]

     

    * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.

     

    LOGO         

        

    Have the 12 digit control number located in the box above available when you access the website and follow the instructions.

    SEE REVERSE FOR FULL AGENDA     

    Copyright © 2026 BetaNXT, Inc. or its affiliates. All Rights Reserved    


    LOGO    Guardian Pharmacy Services, Inc. Annual Meeting of Stockholders

    THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

    FOR each of the nominees listed in PROPOSAL 1, FOR PROPOSALS 2 and 4 and for 1 YEAR on PROPOSAL 3.

     

     

     

    PROPOSAL

     

     

    1.    To elect Class II directors, to hold office until the annual meeting of stockholders to be held in 2029 and until their successors are duly elected and qualified.   
       1.01 John Ackerman   
       1.02 Randall Lewis   
    2.    To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers.   
    3.    To approve, on a non-binding advisory basis, the frequency of the Company’s future advisory votes to approve the compensation of the Company’s named executive officers.   
    4.    To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.   
    Get the next $GRDN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRDN

    DatePrice TargetRatingAnalyst
    10/10/2025$30.00Outperform
    Oppenheimer
    10/21/2024$21.00Outperform
    Raymond James
    10/21/2024$22.00Buy
    Truist
    More analyst ratings

    $GRDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oppenheimer initiated coverage on Guardian Pharmacy Services with a new price target

    Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00

    10/10/25 8:37:40 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Raymond James initiated coverage on Guardian Pharmacy Services with a new price target

    Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

    10/21/24 8:25:47 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Truist initiated coverage on Guardian Pharmacy Services with a new price target

    Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

    10/21/24 7:42:42 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Burke Fred

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/24/26 4:15:11 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Morris David K

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/24/26 4:15:13 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 4 filed by Pharmacy Investors, Llc

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    3/24/26 4:15:14 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    SEC Filings

    View All

    SEC Form DEFA14A filed by Guardian Pharmacy Services Inc.

    DEFA14A - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    3/26/26 7:20:13 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form DEF 14A filed by Guardian Pharmacy Services Inc.

    DEF 14A - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

    3/26/26 7:18:01 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SCHEDULE 13D/A filed by Guardian Pharmacy Services Inc.

    SCHEDULE 13D/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    3/24/26 6:17:38 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the pricing of its upsized underwritten public offering (the "Offering") of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of Class A common stock at the public offering price, less the underwriting discount. The Offering is expected to cl

    3/19/26 6:10:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN) today announced the launch of a proposed underwritten public offering (the "Offering") of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive "synthetic secondary" transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of Class A common stock at the public offering price, less the underwriting discount. The proposed Offering is considered non-dilutive as Guardian inte

    3/18/26 4:20:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted

    3/11/26 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cosler Steven D bought $99,786 worth of shares (3,370 units at $29.61), increasing direct ownership by 16% to 24,984 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    12/5/25 4:10:03 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Cosler Steven D bought $148,540 worth of shares (7,000 units at $21.22), increasing direct ownership by 65% to 17,713 units (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    11/20/24 4:05:12 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Salentine Thomas J Jr bought $499,996 worth of shares (35,714 units at $14.00) (SEC Form 4)

    4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

    10/1/24 5:48:50 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Leadership Updates

    Live Leadership Updates

    View All

    Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations

    Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

    5/8/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy

    Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

    12/17/24 9:00:00 AM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Financials

    Live finance-specific insights

    View All

    Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the fourth quarter and full year ended December 31, 2025. The Company also raised its full-year 2026 Adjusted EBITDA guidance. Fourth Quarter Financial Results Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. Residents served ended the quarter at approximately 205,000, up 10% year-over-year. Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. Adjusted EBITDA of $39.5 million, up 53% year over year. Diluted EPS of $0.33 for the quarter, with Adjusted

    3/11/26 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call

    Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "93533." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian

    2/9/26 4:30:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

    Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

    11/10/25 4:05:00 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $GRDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    12/6/24 12:05:09 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 4:30:13 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G filed by Guardian Pharmacy Services Inc.

    SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

    11/14/24 1:01:24 PM ET
    $GRDN
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples